Simran Farms Ltd

📊 Simran Farms Q2 FY2025 Results: Key Financial Highlights

- Board approved Un-Audited Financial Results for Q2 & H1 ending 30 Sept 2025 (Standalone & Consolidated)

- Borrowing limit increased from ₹100Cr to ₹150Cr

- Subsidiary Puregene Biotech reported ₹13.5L quarterly revenue (₹27L half-yearly)

- Standalone net profit (H1): ₹105.88L | Consolidated: ₹111.56L

- Paid-up equity share capital remains steady at ₹379.17L

- Results reviewed by Khandelwal Kakani & Co (no material misstatements)